VHT
$327.15-0.61%
as of close, Oct 16, 2026
☾ AH $327.15 -0.61%
Vanguard Health Care ETFETF · Sectors
VHT holdings (2026)
All 401 positions in Vanguard Health Care ETF, ranked by portfolio weight — led by LLY at 13.6%. Positions in stocks ChartRow doesn't track still appear, ranked by weight, without returns. Not investment advice.
Holdings as of May 31, 2026, the fund’s latest quarterly SEC report. Weights are updated to today’s prices (as of market close, Oct 16, 2026) — an estimate of today, not the filed figure; switch the table below to see them as filed.
Holdings
401
positions in the latest filing
Largest holding
13.6%
LLY · estimated today
Top 10 weight
52%
concentration · estimated today
On ChartRow
98.8%
fund weight in tickers ChartRow tracks
Holdings as of
May 31, 2026
latest quarterly SEC report
Top 10 holdings#
CompanyWeight1D
Sector weights#
SectorWeight
Healthcare
97.3%
Not on ChartRow
1.2%
Technology
0.9%
Industrials
0.4%
Consumer Discretionary
0.1%
Financials
0.0%
Consumer Staples
0.0%
Estimated portfolio characteristics#
Median P/E
29.6
per member, trailing
P/B
4.8
weighted
Dividend yield
1.33%
weighted
Earnings growth
-18.8%
aggregate TTM, YoY
Avg market cap
$337B
weighted
Estimated by our own bottom-up analysis of the fund’s SEC-filed holdings, covering 99% of portfolio weight (89% carries a valid trailing P/E). Funds publish similar figures on their own sites; ours are recomputed daily from public data.
VHT holdings by weight#
1–100 of 401Weightsthe May 31, 2026 filing rolled forward on price — an estimate (as of market close, Oct 16, 2026)
| # | Company | Weight | Price | 1D | YTD total | 1Y total | Mkt cap |
|---|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly and Company | 13.64% | $1,257.32 | +0.46% | +17.53% | +54.38% | $1.12T |
| 2 | JNJJohnson & Johnson | 8.20% | $255.56 | +0.90% | +25.48% | +36.02% | $616B |
| 3 | ABBVAbbVie Inc. | 6.81% | $285.38 | +0.70% | +28.65% | +29.57% | $504B |
| 4 | UNHUnitedHealth Group Incorporated Common Stock (DE) | 4.91% | $401.41 | -1.29% | +24.01% | +15.55% | $360B |
| 5 | MRKMerck & Co. Inc. | 4.89% | $145.96 | +0.53% | +41.52% | +79.02% | $360B |
| 6 | TMOThermo Fisher Scientific Inc. | 3.50% | $690.33 | -0.88% | +19.41% | +29.00% | $255B |
| 7 | AMGNAmgen Inc. | 3.14% | $432.56 | -0.34% | +34.84% | +50.26% | $234B |
| 8 | GILDGilead Sciences Inc. | 2.62% | $156.19 | -0.75% | +29.54% | +35.81% | $194B |
| 9 | ABTAbbott Laboratories | 2.46% | $104.89 | +0.20% | -14.20% | -15.77% | $181B |
| 10 | PFEPfizer Inc. | 2.27% | $29.57 | +0.44% | +24.93% | +30.64% | $169B |
| 11 | ISRGIntuitive Surgical Inc. | 2.04% | $426.71 | -0.27% | -24.66% | -1.82% | $151B |
| 12 | DHRDanaher Corporation | 1.97% | $229.03 | -1.07% | +0.65% | +9.39% | $161B |
| 13 | VRTXVertex Pharmaceuticals Incorporated | 1.71% | $499.78 | -1.76% | +10.23% | +22.30% | $127B |
| 14 | MCKMcKesson Corporation | 1.67% | $1,005.38 | +0.67% | +22.87% | +30.09% | $117B |
| 15 | BMYBristol-Myers Squibb Company | 1.64% | $59.85 | -1.20% | +15.70% | +43.83% | $122B |
| 16 | MDTMedtronic plc. | 1.64% | $94.77 | -0.71% | +1.16% | +3.00% | $121B |
| 17 | CVSCVS Health Corporation | 1.58% | $92.36 | -0.24% | +19.10% | +17.11% | $118B |
| 18 | SYKStryker Corporation | 1.37% | $294.67 | +0.49% | -15.45% | -19.32% | $113B |
| 19 | ELVElevance Health Inc. | 1.26% | $428.00 | -0.10% | +23.96% | +25.45% | $93B |
| 20 | REGNRegeneron Pharmaceuticals Inc. | 1.10% | $790.95 | -0.68% | +2.84% | +39.64% | $81B |
| 21 | CIThe Cigna Group | 1.09% | $302.52 | +1.24% | +11.70% | +6.21% | $80B |
| 22 | HCAHCA Healthcare Inc. | 0.99% | $458.55 | -2.12% | -1.19% | +10.10% | $99B |
| 23 | MRNAModerna Inc. | 0.89% | $218.00 | -7.82% | +639.27% | +703.28% | $87B |
| 24 | BSXBoston Scientific Corporation | 0.89% | $44.39 | +0.56% | -53.45% | -54.60% | $64B |
| 25 | CORCencora Inc. | 0.85% | $340.81 | -0.18% | +1.54% | +7.55% | $65B |
| 26 | CAHCardinal Health Inc. | 0.81% | $254.00 | +0.11% | +24.80% | +67.32% | $59B |
| 27 | BDXBecton Dickinson and Company | 0.74% | $191.55 | -1.14% | +28.12% | +35.14% | $52B |
| 28 | NTRANatera Inc. | 0.70% | $393.54 | -2.78% | +71.74% | +117.92% | $57B |
| 29 | EWEdwards Lifesciences Corporation | 0.68% | $86.60 | -1.70% | +1.58% | +19.20% | $50B |
| 30 | HUMHumana Inc. | 0.67% | $413.37 | -4.36% | +62.51% | +56.26% | $50B |
| 31 | AAgilent Technologies Inc. | 0.66% | $172.96 | -1.48% | +28.07% | +23.51% | $49B |
| 32 | VEEVVeeva Systems Inc. | 0.65% | $310.37 | -0.85% | +39.03% | +6.02% | $50B |
| 33 | IQVIQVIA Holdings Inc. | 0.61% | $266.89 | -1.53% | +18.41% | +29.72% | $44B |
| 34 | IDXXIDEXX Laboratories Inc. | 0.60% | $560.50 | +2.43% | -17.17% | -12.08% | $44B |
| 35 | WATWaters Corporation | 0.58% | $436.96 | -1.62% | +15.04% | +30.48% | $43B |
| 36 | ILMNIllumina Inc. | 0.54% | $262.50 | -2.03% | +100.17% | +173.74% | $40B |
| 37 | ZTSZoetis Inc. | 0.47% | $79.36 | +1.20% | -35.92% | -43.53% | $33B |
| 38 | RMDResMed Inc. | 0.47% | $239.01 | -1.33% | +0.02% | -10.56% | $34B |
| 39 | BIIBBiogen Inc. | 0.46% | $232.65 | -1.15% | +32.20% | +63.54% | $34B |
| 40 | CNCCentene Corporation | 0.46% | $69.16 | -1.92% | +68.07% | +94.05% | $34B |
| 41 | DXCMDexCom Inc. | 0.45% | $86.04 | -1.90% | +29.64% | +29.72% | $32B |
| 42 | MTDMettler-Toledo International Inc. | 0.45% | $1,622.00 | -1.04% | +16.36% | +19.32% | $32B |
| 43 | GEHCGE HealthCare Technologies Inc. Common Stock | 0.43% | $69.57 | -1.11% | -15.06% | -5.01% | $31B |
| 44 | ALNYAlnylam Pharmaceuticals Inc. | 0.41% | $231.85 | -0.93% | -41.70% | -51.81% | $31B |
| 45 | RVMDRevolution Medicines Inc. | 0.39% | $178.07 | -5.91% | +123.43% | +258.21% | $38B |
| 46 | WSTWest Pharmaceutical Services Inc. | 0.37% | $383.83 | +0.21% | +39.90% | +44.17% | $27B |
| 47 | LHLabcorp Holdings Inc. | 0.36% | $317.84 | -2.22% | +27.67% | +13.20% | $26B |
| 48 | DGXQuest Diagnostics Incorporated | 0.35% | $234.80 | -1.82% | +37.70% | +27.90% | $26B |
| 49 | THCTenet Healthcare Corporation | 0.32% | $267.33 | -2.83% | +34.49% | +34.21% | $22B |
| 50 | STESTERIS plc (Ireland) | 0.29% | $222.67 | -0.74% | -11.42% | -6.54% | $22B |
| 51 | UTHRUnited Therapeutics Corporation | 0.29% | $533.32 | -1.51% | +9.41% | +23.21% | $23B |
| 52 | VTRSViatris Inc. | 0.29% | $18.66 | +2.41% | +53.37% | +91.25% | $21B |
| 53 | INSMInsmed Incorporated | 0.28% | $96.27 | -2.97% | -44.69% | -41.01% | $21B |
| 54 | INCYIncyte Corp. | 0.25% | $113.13 | -0.12% | +14.48% | +29.50% | $23B |
| 55 | ZBHZimmer Biomet Holdings Inc. | 0.25% | $94.97 | +0.63% | +6.48% | -3.93% | $18B |
| 56 | GHGuardant Health Inc. | 0.24% | $158.70 | -4.33% | +55.28% | +135.07% | $21B |
| 57 | RVTYRevvity Inc. | 0.23% | $152.62 | -1.35% | +58.09% | +62.83% | $17B |
| 58 | EXELExelixis Inc. | 0.21% | $62.25 | -0.92% | +41.98% | +58.71% | $15B |
| 59 | CRLCharles River Laboratories | 0.20% | $300.36 | -1.92% | +50.47% | +71.56% | $14B |
| 60 | HALOHalozyme Therapeutics Inc. | 0.19% | $121.83 | +0.26% | +81.04% | +82.18% | $14B |
| 61 | MEDPMedpace Holdings Inc. | 0.19% | $618.40 | -1.62% | +10.12% | +18.66% | $17B |
| 62 | Vanguard Cmt Funds-Vanguard Market Liquidity Fund | 0.19% | — | — | — | — | — |
| 63 | NBIXNeurocrine Biosciences Inc. | 0.18% | $135.77 | -0.86% | -4.32% | -1.32% | $14B |
| 64 | SOLVSolventum Corporation | 0.18% | $85.81 | -2.33% | +8.29% | +20.11% | $15B |
| 65 | BAXBaxter International | 0.18% | $25.28 | -1.88% | +32.47% | +10.27% | $13B |
| 66 | EHCEncompass Health Corporation | 0.17% | $127.85 | +0.06% | +21.36% | +4.73% | $13B |
| 67 | ROIVRoivant Sciences Ltd. | 0.17% | $33.52 | -1.53% | +54.52% | +95.97% | $24B |
| 68 | PENPenumbra Inc. | 0.16% | $320.86 | -0.11% | +3.20% | +26.40% | $13B |
| 69 | ELANElanco Animal Health Incorporated | 0.16% | $23.56 | +0.08% | +4.07% | +14.77% | $12B |
| 70 | JAZZJazz Pharmaceuticals plc Common Stock (Ireland) | 0.16% | $210.19 | -1.97% | +23.66% | +56.60% | $14B |
| 71 | COOThe Cooper Companies Inc. | 0.15% | $57.93 | +0.92% | -29.31% | -19.03% | $11B |
| 72 | TECHBio-Techne | 0.15% | $72.57 | +0.07% | +23.93% | +18.48% | $11B |
| 73 | AVTRAvantor Inc. | 0.15% | $16.42 | +2.05% | +43.28% | +12.70% | $11B |
| 74 | MOHMolina Healthcare Inc | 0.14% | $207.36 | -2.42% | +19.49% | +9.97% | $11B |
| 75 | CORTCorcept Therapeutics Incorporated | 0.14% | $110.15 | -2.84% | +216.55% | +38.62% | $12B |
| 76 | ENSGThe Ensign Group Inc. | 0.14% | $176.65 | -0.82% | +1.51% | -1.44% | $10B |
| 77 | UHSUniversal Health Services | 0.14% | $185.14 | -1.18% | -14.80% | -8.98% | $11B |
| 78 | ALGNAlign Technology Inc. | 0.14% | $147.31 | -1.36% | -5.66% | +13.46% | $10B |
| 79 | BMRNBioMarin Pharmaceutical Inc. | 0.13% | $54.68 | -2.44% | -7.99% | +3.27% | $11B |
| 80 | PODDInsulet Corporation | 0.13% | $141.00 | +1.61% | -50.36% | -55.39% | $10B |
| 81 | BBIOBridgeBio Pharma Inc. | 0.13% | $66.38 | -1.12% | -13.20% | +20.64% | $13B |
| 82 | GKOSGlaukos Corporation | 0.13% | $164.85 | -0.45% | +45.99% | +93.18% | $10B |
| 83 | RGENRepligen Corporation | 0.13% | $175.41 | -4.76% | — | — | $10B |
| 84 | MDLNMedline Inc. | 0.13% | $35.96 | -1.68% | -14.38% | — | $47B |
| 85 | HSICHenry Schein | 0.12% | $86.34 | -0.75% | +14.29% | +39.26% | $10B |
| 86 | BTSGBrightSpring Health Services Inc. | 0.12% | $60.88 | -2.37% | +62.54% | +106.69% | $12B |
| 87 | GMEDGlobus Medical Inc. | 0.12% | $76.69 | -2.73% | -12.14% | +30.97% | $10B |
| 88 | Masimo Corp | 0.11% | — | — | — | — | — |
| 89 | TGTXTG Therapeutics Inc. | 0.11% | $54.00 | -3.57% | — | — | $8B |
| 90 | TWSTTwist Bioscience Corporation | 0.11% | $132.85 | -8.06% | +318.51% | +331.71% | $8B |
| 91 | HQYHealthEquity Inc. | 0.11% | $92.09 | -0.45% | — | — | $8B |
| 92 | PCVXVaxcyte Inc. | 0.10% | $63.61 | -2.55% | — | — | $9B |
| 93 | TXG10x Genomics Inc. | 0.10% | $69.87 | -3.48% | +328.33% | +464.30% | $9B |
| 94 | DVADaVita Inc. | 0.10% | $187.33 | -0.97% | +64.87% | +49.55% | $12B |
| 95 | CHEChemed Corp | 0.10% | $512.18 | -0.63% | — | — | $7B |
| 96 | CYTKCytokinetics Incorporated | 0.10% | $61.99 | -3.02% | -2.50% | +5.07% | $8B |
| 97 | KRYSKrystal Biotech Inc. | 0.09% | $316.69 | -4.03% | +28.41% | +68.10% | $9B |
| 98 | ARWRArrowhead Pharmaceuticals Inc. | 0.09% | $55.91 | -4.43% | -15.80% | +43.44% | $8B |
| 99 | MDGLMadrigal Pharmaceuticals Inc. | 0.09% | $449.53 | -2.24% | -22.77% | +1.72% | $10B |
| 100 | LNTHLantheus Holdings Inc. | 0.09% | $99.69 | -0.30% | — | — | $7B |
Methodology#
Holdings and weights are sourced from the fund’s portfolio as disclosed to the SEC on Form N-PORT — a public filing. Portfolio filings are quarterly (public ~60 days after quarter end), so we anchor on the latest one and roll each weight forward daily by that holding’s price move, keeping the numbers current between filings; positions in stocks ChartRow doesn’t track carry their filed weight unchanged and show “—” where we have no data. Returns are total returns (dividends reinvested). One row per company, not per ticker: when a fund holds more than one share class of the same company (Alphabet’s GOOGL and GOOG, for example), we combine them into a single row whose weight is the sum of its classes. Past performance does not predict future returns; not investment advice.
FAQ#
- What are the top 10 holdings of VHT?
- VHT's top 10 holdings are Eli Lilly and Company (LLY), 13.6%; Johnson & Johnson (JNJ), 8.2%; AbbVie Inc. (ABBV), 6.8%; UnitedHealth Group Incorporated Common Stock (DE) (UNH), 4.9%; Merck & Co. Inc. (MRK), 4.9%; Thermo Fisher Scientific Inc. (TMO), 3.5%; Amgen Inc. (AMGN), 3.1%; Gilead Sciences Inc. (GILD), 2.6%; Abbott Laboratories (ABT), 2.5%; Pfizer Inc. (PFE), 2.3% — together about 52% of the fund, per its May 31, 2026 SEC filing with weights rolled forward to today.
- How many holdings does VHT have?
- Vanguard Health Care ETF (VHT) held 401 positions as of May 31, 2026, the date of its latest public portfolio report to the SEC.
- How current are VHT's holdings?
- The list of holdings is as of May 31, 2026. Funds report their full portfolio to the SEC on Form N-PORT, and the report for the last month of each fiscal quarter becomes public about 60 days after that month ends, so the newest public portfolio is always two to five months old. Between reports ChartRow updates each weight daily by that holding's price move, so the weights estimate today; the positions themselves change only when the next report is published. A fund's own website may list more recent holdings.
- Is ChartRow affiliated with VHT or Vanguard?
- No. ChartRow is independent and is not affiliated with, sponsored by, or endorsed by Vanguard or Vanguard Health Care ETF. Everything on this page is derived independently from the fund's public SEC filings; fund names and trademarks belong to their owners. For information only — not investment advice.